High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease

International Review of Psychiatry

Volumn 18, Issue 2, 2006, Pages 149-154

  Puri, Basant K ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; ICOSAPENTAENOIC ACID;

ACCURACY; BRAIN; CHRONIC FATIGUE SYNDROME; DEPRESSION; FOURIER ANALYSIS; HUMAN; HUNTINGTON CHOREA; LATERAL BRAIN VENTRICLE; MENTAL DISEASE; NEUROLOGIC DISEASE; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ATROPHY; BRAIN; DEPRESSIVE DISORDER; FATIGUE SYNDROME, CHRONIC; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEURONAL PLASTICITY; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY;

EID: 33646933862     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260600583015     Document Type: Review

References (22)

1. Bydder, G. M., & Hajnal, J. V. (1997). Registration and subtraction of serial MRI - Part 2: Image interpretation. In W. G. Bradley & G. M. Bydder (Eds.), Advanced MR Imaging Techniques. London: Martin Dunitz Freeman.
2. Gonzalez, R. C., & Woods, R. E. (1992). Digital Image Processing. New York: Addison-Wesley.
3. Hajnal, J. V., Saeed, N., Soar, E. J., Oatridge, A., Young, I. R., & Bydder, G. M. (1995). A registration and interpolation procedure for subvoxel matching of serially acquired MR images. Journal of Computer Assisted Tomography, 19, 289-296.
4. Hajnal, J. V., & Bydder, G. M. (1997). Registration and subtraction of serial MRI - Part 1: Technique. In W. G. Bradley & G. M. Bydder (Eds.), Advanced MR Imaging Techniques. London: Martin Dunitz Freeman.
5. Herman, G. T., & Liu, H. K. (1978). Dynamic boundary surface detection. Computer Graphics Image Processing, 7, 130-138.
6. Jain, A. K. (1989). Fundamentals of Digital Image Processing. Englewood Cliffs: Prentice Hall.
7. Marshall, S., Saeed, N., Young, I. H., Durrani, T. S., Dalton, B., & DuBoulay, G. (1990). System for automatic patient realignment of the head in magnetic resonance imaging. IEEE Proceedings, Artificial Intelligence in Signal Processing, 137, 319-330.
8. Puri, B. K. (2003a). A possible role for fatty acid treatment in paediatric depression. In M. Peet, I. Glen & D. F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology (pp. 543-548). Carnforth: Marius Press.
9. Puri, B. K. (2003b). A randomised trial of ethyl eicosapentaenoate in patients with end-stage Huntington's disease. In M. Peet, I. Glen & D. F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology (pp. 575-579). Carnforth: Marius Press.
10. Puri, B. K. (2004a). Monomodal rigid-body registration and applications to the investigation of the effects of eicosapentaenoic acid intervention in neuropsychiatric disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids, 71, 177-179.
11. Puri, B. K. (2004b). The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins, Leukotrienes and Essential Fatty Acids, 70, 399-401.
12. Puri, B. K. (2005). Chronic fatigue syndrome. London: Hammersmith Press.
13. Puri, B. K., & Richardson, A. J. (1998). Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Archives of General Psychiatry, 55, 188-189.
14. Puri, B. K., & Richardson, A. J. (2003). Long-term follow-up of a single patient with schizophrenia treated with ethyl-EPA alone. In M. Peet, I. Glen & D. F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology (pp. 377-389). Carnforth: Marius Press.
15. Puri, B. K., Bydder, G. M., Counsell, S. J., et al. (2002b). MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. NeuroReport, 13, 123-126.
16. Puri, B. K., Counsell, S. J., Hamilton, G., Richardson, A. J., & Horrobin, D. F. (2001). Eicosapentaenoic acid treatment in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice, 55, 560-563.
17. Puri, B. K., Counsell, S. J., Richardson, A. J., & Horrobin, D. F. (2002a). Eicosapentaenoic acid in treatment-resistant depression. Archives of General Psychiatry, 59, 91-92.
18. Puri, B. K., Holmes, J., & Hamilton, G. (2004). Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. International Journal of Clinical Practice, 58, 297-299.
19. Puri, B. K., Richardson, A. J., Horrobin, D. F., et al. (2000). Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. International Journal of Clinical Practice, 54, 57-63.
20. Saeed, N. (1990). Application of digital image processing in magnetic resonance scanning. PhD thesis, Signal Processing Division. Glasgow: University of Strathclyde.
21. Saeed, N., Puri, B. K., Oatridge, A., Hajnal, J. V., & Young, I. R. (1998). Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia. Magnetic Resonance Imaging, 16, 1237-1247.
22. Vaddadi, K. S. (2003). Essential fatty acids in the treatment of Huntington's disease. In M. Peet, I. Glen & D. F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology (pp. 565-574). Carnforth: Marius Press.